Dr. Martin Garnett
PhD, BSc Biochemistry
Associate Professor in Drug Delivery
School of Pharmacy
| Phone: | +44 (0) 115 9515045 |
|---|---|
| Fax: | +44 (0) 115 9515102 |
| Email: | martin.garnett@nottingham.ac.uk |
| Web: | http://www.cbtrc.org/martin_garnett |
My research interests include a wide range of drug delivery technologies based on polymers and nanotechnology, but particularly involving the delivery of biomolecules and incorporating various targeting strategies. My research incorporates many aspects of drug delivery including assembly and characterisation of delivery systems. Characterisation includes the physicochemical aspects of the delivery system, the drug incorporation and release characteristics, and also the interaction of the delivery systems with biological systems both in vitro and in vivo.

Dr. Martin Garnett and his research team
Evaluation of poly (glycerol-adipate) nanoparticle uptake in an in vitro 3-D brain tumour co-culture model. Meng W, Kallinteri P, Walker DA, Parker T, Garnett MC. Exp. Biol. Med. (2007, In Press).
Development of a slow non-viral DNA release system from PDLLA scaffolds fabricated using a supercritical CO 2 technique. Mieke Heyde, Kris A. Partridge, Steven M. Howdle, Richard O.C. Oreffo, Martin C. Garnett, Kevin M. Shakesheff. Biotechnology and Bioengineering (2007, In Press).
Biodistribution of Nanoparticles: Insights from Drug delivery, Garnett MC , In Monteiro Riviere and Tran (eds): Characterisation, dosing and Health Effects, Informa Healthcare NY, USA. (In press 2007).
Nanomedicines and nanotoxicology: some physiological principles (2006). Garnett MC and Kallinteri P. Occupational Medicine 56 307-311.
Gene therapy used for tissue engineering applications. M Heyde, K Partridge, R Oreffo, S Howdle, K Shakesheff, & M Garnett. J Pharm Pharmacol (In press 2006).
Polymeric Nanoparticles for Drug Delivery, P. Kallinteri and M C Garnett (2006). In "Nanotechnologies for Life Sciences, Volume 9. "Nanotechnologies for Diagnosis and Drug delivery. Wiley-VCH.
Uptake and metabolism of novel biodegradable poly (glycerol-adipate) nanoparticles in DAOY monolayer (2006). Meng W, Parker TL, Kallinteri P, Walker DA, Higgins S, Hutcheon GA, Garnett MC. J Contr Rel, 116: 314-321.
Differences in the adsorption behaviour of poly(ethylene oxide) copolymers onto model polystyrene nanoparticles assessed by isothermal titration microcalorimetry correspond to the biological differences (2005). Stolnik S. Heald CR. Garnett MG. Illum L. Davis SS. Journal of Drug Targeting. Vol. 13 449-458.
Nanomedicines: Delivering drugs using bottom up nanotechnology (2005), MC Garnett, Int J Nanoscience, 4, 855-861.